By rray, 26 January, 2024 If AF lasts 5min to 24h w CHA2DS2 VASc 3 reasonable to anticoagulate w shared decision making and based on individual pt risk
By rray, 26 January, 2024 If AF lasts 24h w CHA2DS2 VASc 2 in men 3 in women reasonable to anticoagulate w shared decision making and based on individual pt risk
By rray, 26 January, 2024 Decision to anticoagulate is based on length of AF episodes and stroke risk Device detected AF is assoc w lower stroke risk than clinical AF Confirm duration and nature of longest device detected episode Assess stroke risk e g CHA2DS2 VASc
By rray, 26 January, 2024 Provide ongoing monitoring for progression to clinical AF and change in stroke risk
By rray, 26 January, 2024 If no AF on 12 lead diagnose subclinical AF If AF on 12 lead treat as clinical AF 1
By rray, 26 January, 2024 AF may be detected w reliable monitoring device wearable continuous or loop recording devices implantable loop recorders pacemakers defibrillators and confirmed by physician review Smartphones smartwatches can discriminate AF vs NSR but are not reliable e